MyoVasc-Kohortenstudie


Förderkennzeichen

81Z2210101

Projektnummer

456

Institution
Universitätsmedizin der Johannes Gutenberg-Universität Mainz
Projektleiter
Philipp Wild
Standort
RheinMain
Kurzbeschreibung

The Myovasc Study is a prospective cohort study investigating heart failure and its interactions with vascular disease. From January 2013 to January 2017 approximately 3000 participants … 

The Myovasc Study is a prospective cohort study investigating heart failure and its interactions with vascular disease. From January 2013 to January 2017 approximately 3000 participants with asymptomatic and symptomatic heart failure are eligible for the study. The primary outcome of interest is worsening of heart failure, defined as transition of cardiac dysfunction to symptomatic heart failure or cardiac death in asymptomatic individuals and hospitalization or cardiac death in symptomatic heart failure. Study participants start with a 5-hour baseline examination including comprehensive cardiovascular diagnostics. A follow up with the same examination program is performed after 2 and 4 years. A computer-assisted telephone interview with assessment of outcome is conducted yearly.

Projektart
Standortprojekt
Stichwörter
Heart Failure, vascular function, Biodatabanking, phenomics, cohort study
Fördersumme
€ 2.445.809,00
Beginn
01.01.2015
Ende
31.12.2018